Skip to main content
. 2013 May 8;33(19):8567–8574. doi: 10.1523/JNEUROSCI.5810-12.2013

Table 1.

Participants' characteristics and whole brain measures

Control (n = 27) Turner
Xm (n = 23) Xp (n = 17)
Demographics
    Age 8.17 (2.93) 7.93 (2.63) 9.25 (2.61)
    Growth hormone 20 (87%) 14 (76%)
Cognitive measures
    FSIQabc 113.63 (8.57) 97.09 (14.05) 88.88 (12.46)
    PRI/PIQabc 114.19 (11.78) 97.48 (15.10) 86.12 (13.16)
    VCI/VIQab 113.63 (13.33) 105.00 (12.13) 99.76 (14.36)
    WMIab 102.16 (10.66) 86.19 (13.30) 87.13 (13.55)
    PSI/PSQab 108.84 (10.65) 92.48 (12.82) 88.11 (13.27)
Whole- brain measures
    Total brain volume 1029.76 (98.29) 1053.21 (82.02) 1004.51 (109.81)
    Total GMV 593.24 (47.77) 616.34 (53.08) 579.56 (44.85)
    Total WMV 436.98 (32.65) 425.98 (36.15) 429.67 (44.50)
    Total surface areab 1716.72 (187.9) 1734.29 (156.26) 1616.91 (170.98)
    Mean cortical thickness 2.77 (0.12) 2.79 (0.13) 2.82 (0.11)

Xm, X chromosome from maternal origin; Xp, paternal origin. FSIQ, Full-Scale Intelligence Quotient; PRI/PIQ, Performance Intelligence Quotient; VCI/VIQ, Verbal Intelligence Quotient. Significant post hoc difference (p < 0.05) between groups are indicated by letters in superscript:

aControls versus Xm,

bControls versus Xp, and

cXm versus Xp. Pearson χ2 was performed on growth hormone usage (p = 0.339, n.s.). ANCOVAs were used to assess between-group differences in total brain volume (age as covariate), total surface area, and mean cortical thickness (age and total brain volume as covariates). Volumes are expressed in cm3, area in cm2, and thickness in mm. Numbers represent mean values with standard deviation in parentheses.